Philip M Urban

Summary

Country: Switzerland

Publications

  1. ncbi request reprint Thrombosis: the last frontier of coronary stenting?
    Philip Urban
    Cardiovascular Department, La Tour Hospital, 1217 Geneva, Switzerland
    Lancet 369:619-21. 2007
  2. ncbi request reprint A multicentre European registry of intraluminal coronary beta brachytherapy
    P Urban
    Cardiovascular Department, La Tour Hospital, Avenue Maillard 1, 1217, Geneva, Switzerland
    Eur Heart J 24:604-12. 2003
  3. doi request reprint Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
    Philip Urban
    Hopital de la Tour, Geneva, Switzerland
    Am Heart J 165:704-9. 2013
  4. ncbi request reprint [Cardiovascular cooperation with the BPKIHS Hospital, in Dharan Bazar, Nepal]
    P Urban
    Service de cardiologie Hôpital de la Tour, Meyrin Genève
    Rev Med Suisse 9:498-501. 2013
  5. doi request reprint Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry
    Philip Urban
    La Tour Hospital, 1 Avenue JD Maillard, Geneva, Switzerland
    J Am Coll Cardiol 57:1445-54. 2011
  6. doi request reprint Impact of changing definitions for myocardial infarction: a report from the AMIS registry
    Philip Urban
    Cardiovascular Department, La Tour Hospital, Geneva, Switzerland
    Am J Med 121:1065-71. 2008
  7. ncbi request reprint [Treatment of acute myocardial infarction in 2007]
    Philip Urban
    Département cardiovasculaire, Hopital de la Tour, 1217 Meyrin
    Rev Med Suisse 3:648-50, 652-3. 2007
  8. ncbi request reprint Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry
    Philip Urban
    La Tour Hospital, Geneva, Switzerland
    Circulation 113:1434-41. 2006
  9. ncbi request reprint [The e-Cypher registry: objectives and organization]
    P Urban
    Département cardiovasculaire, Hôpital La Tour, Avenue Maillard 1, 1217 Meyrin Genève, Suisse
    Ann Cardiol Angeiol (Paris) 53:18s-21s. 2004
  10. ncbi request reprint In-hospital mortality associated with the use of intra-aortic balloon counterpulsation
    Philip M Urban
    La Tour Hospital, Geneva, Switzerland
    Am J Cardiol 94:181-5. 2004

Detail Information

Publications15

  1. ncbi request reprint Thrombosis: the last frontier of coronary stenting?
    Philip Urban
    Cardiovascular Department, La Tour Hospital, 1217 Geneva, Switzerland
    Lancet 369:619-21. 2007
  2. ncbi request reprint A multicentre European registry of intraluminal coronary beta brachytherapy
    P Urban
    Cardiovascular Department, La Tour Hospital, Avenue Maillard 1, 1217, Geneva, Switzerland
    Eur Heart J 24:604-12. 2003
    ..To assess the feasibility, safety and effectiveness of intravascular brachytherapy (VBT) in routine clinical practice...
  3. doi request reprint Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
    Philip Urban
    Hopital de la Tour, Geneva, Switzerland
    Am Heart J 165:704-9. 2013
    ..It is therefore reasonable to consider that such a device may have a potential safety advantage, and a lesser dependence on prolonged DAPT than a polymer-coated drug-eluting stent...
  4. ncbi request reprint [Cardiovascular cooperation with the BPKIHS Hospital, in Dharan Bazar, Nepal]
    P Urban
    Service de cardiologie Hôpital de la Tour, Meyrin Genève
    Rev Med Suisse 9:498-501. 2013
    ....
  5. doi request reprint Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry
    Philip Urban
    La Tour Hospital, 1 Avenue JD Maillard, Geneva, Switzerland
    J Am Coll Cardiol 57:1445-54. 2011
    ..The aim of this study was to ascertain the 1-year incidence of stent thrombosis (ST) and major bleeding (MB) in a large, unselected population treated with sirolimus-eluting stents (SES)...
  6. doi request reprint Impact of changing definitions for myocardial infarction: a report from the AMIS registry
    Philip Urban
    Cardiovascular Department, La Tour Hospital, Geneva, Switzerland
    Am J Med 121:1065-71. 2008
    ....
  7. ncbi request reprint [Treatment of acute myocardial infarction in 2007]
    Philip Urban
    Département cardiovasculaire, Hopital de la Tour, 1217 Meyrin
    Rev Med Suisse 3:648-50, 652-3. 2007
    ..ACE inhibitors should be continued in case of high blood pressure, heart failure or a left ventricular ejection fraction < 40%. The main benefit of betablockers is for patients with residual angina and/or chronic heart failure...
  8. ncbi request reprint Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry
    Philip Urban
    La Tour Hospital, Geneva, Switzerland
    Circulation 113:1434-41. 2006
    ..The e-Cypher registry monitored the safety and efficacy of SES currently implanted worldwide in daily practice...
  9. ncbi request reprint [The e-Cypher registry: objectives and organization]
    P Urban
    Département cardiovasculaire, Hôpital La Tour, Avenue Maillard 1, 1217 Meyrin Genève, Suisse
    Ann Cardiol Angeiol (Paris) 53:18s-21s. 2004
  10. ncbi request reprint In-hospital mortality associated with the use of intra-aortic balloon counterpulsation
    Philip M Urban
    La Tour Hospital, Geneva, Switzerland
    Am J Cardiol 94:181-5. 2004
    ..Therefore, diagnostic evaluation and treatment decisions should be made as early as possible, and physicians should be aware of associated risk factors in making choices for patients...
  11. ncbi request reprint Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery
    Jan T Christenson
    Department of Cardiovascular Surgery, University Hospital, Geneva, Switzerland
    Ann Thorac Surg 74:1086-90; discussion 1090-1. 2002
    ..Although the efficacy and cost-effectiveness of IABC have been demonstrated, historically higher complication rates have dissuaded some practitioners from using IABC...
  12. ncbi request reprint [Are drug-eluting stents dangerous?]
    Edoardo De Benedetti
    Département cardiovasculaire, Hôpital de LaTour, 1217 Meyrin
    Rev Med Suisse 3:656-8. 2007
    ....
  13. doi request reprint Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world
    Alexandre Meiltz
    Cardiovascular Department, Hopital de la Tour, Meyrin 1217, Geneva, Switzerland
    Europace 10:674-80. 2008
    ..The purpose of this prospective study was to characterize the clinical profile of patients with atrial fibrillation (AF) in cardiology practice and to assess how successfully guidelines have been implemented in real-world practice...
  14. doi request reprint Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland
    Mathieu Schmutz
    Cardiovascular Department, Hopital de la Tour, Geneva, Switzerland
    Europace 12:475-81. 2010
    ..To determine the prevalence of atrial fibrillation (AF) in a population-based sample of adults...
  15. ncbi request reprint Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Am Coll Cardiol 41:1940-5. 2003
    ..We sought to examine contemporary utilization patterns and clinical outcomes in patients with acute myocardial infarction (AMI) requiring intra-aortic balloon pump (IABP) counterpulsation...